Multiple Sclerosis Journal · 2001 · 51 citations · 16 references
Life SciencesImmunologyPathobiologyAutoimmunityImmunopathologyNeuroimmunologyCytokine BiologyCytokine RegulationCytokine-mediated PathologyHelper T Cell SubsetsMultiple SclerosisT Cell BiologyCd4 Positive T CellsCd4 T Cell ActivationCd8 Positive T CellsCd8 T Cell ActivationImmune-mediated PathogenesisMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyNeuroinflammation In Multiple Sclerosis
OBJECTIVE: To evaluate the expression of cytokines in both CD4+ and CD8+ T cells derived from peripheral blood of untreated multiple sclerosis (MS) patients with either relapsing-remitting (RR), secondary progressive (SP) or primary progressive (PP) MS and healthy controls (HC). BACKGROUND: MS is an immune-mediated disease and cytokines hove been hypothesized to contribute significantly to disease progression. Compared to the relapse-onset (RR, SP) form of the disease, PPMS patients have different clinical, immunological and pathological features. Surprisingly, the ability of their circulating T cells to produce immunoregulatory cytokines has not been extensively studied so far. METHODS: Seventy-two MS patients (24 RR, 26 SP, 22 PP) and 34 HC were studied. Stimulated peripheral blood derived CD4+ and CD8+ T MS patients express significantly more CD4+ and CD8+ T cells were analyzed for IFN-gamma, IL-2, TNF-alpha, IL-4, IL-10 and IL-13 production. RESULTS: cells producing IFN-gamma compared to HC. Compared to the other forms of the disease, PPMS patients display a significant decrease in CD4+ T cells producing IL-2, IL-13 and TNF-alpha and a significant increase in CD8+ T cells producing IL-4 and IL-10. CONCLUSIONS: The data presented here demonstrate that patients with PPMS express less pro- and more anti-inflammatory cytokine producing T cells compared to the relapse-onset form of the disease, confirming the view on PPMS as a distinct disease entity.
16
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold · Neurology · 1996 · 3.7K citations
Human TH1 and TH2 subsets: doubt no more
S Romagnani · Immunology Today · 1991 · 1.1K citations
EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON
H. S. Panitch, AndreaS. Haley, RobertL. Hirsch et al. · The Lancet · 1987 · 1.1K citations
Life Sciences, Immunology, Neurology +10
Grahame J. McKenzie, Padraic G. Fallon, Claire Emson et al. · The Journal of Experimental Medicine · 1999 · 351 citations · Full text